Lertpipopmetha Korn, Tubtawee Teeravut, Piratvisuth Teerha, Chamroonkul Naichaya
Department of Internal Medicine, Faculty of Medicine Songklanagarind Hospital, Prince of Songkla University, Songkhla, Thailand. Email:
Asian Pac J Cancer Prev. 2016 Nov 1;17(11):4805-4811. doi: 10.22034/APJCP.2016.17.11.4805.
Background: Hepatocellular carcinomas (HCCs) less than 2 cm in diameter generally demonstrate a good outcome after curative therapy. However, the diagnosis of small HCC can be problematic and requires one or more dynamic imaging modalities. This study aimed to compare the sensitivity and agreement between CT and MRI for the diagnosis of small HCCs. Methods: CT and/or MRI scans of HCCs (1-2 cm) diagnosed by histopathology or typical vascular pattern according to the 2005 AASLD criteria were blindly reviewed by an abdominal radiologist. The reports were defined as conclusive/typical when arterial enhancement and washout during the portal/delayed phases were observed and as inconclusive when typical vascular patterns were not observed. The sensitivity and Cohen’s kappa (k) for agreement were calculated. Results: In 27 patients, 27 HCC nodules (1-2 cm) were included. Diagnosis with a single-imaging modality (CT or MRI) was 81 % versus 48 % (p = 0.01). The CT sensitivity was significantly higher than MRI (78 % versus 52 %, p = 0.04). Among 27 nodules that underwent both CT and MRI, a discordance in typical enhancement patterns was found (k = 0.319, p = 0.05). In cases with inconclusive CT results, MRI gave only an additional 3.7 % sensitivity to reach a diagnosis. In contrast, further CT imaging following inconclusive MRI results gave an additional 29.6 % sensitivity. Conclusions: A single typical imaging modality is sufficient to diagnose small HCCs. Compared with MRI, multiphasic CT has a higher sensitivity. The limitations of MRI could be explained by the greater need for patient cooperation and the types of MRI contrast agent.
直径小于2 cm的肝细胞癌(HCC)在接受根治性治疗后通常预后良好。然而,小肝癌的诊断可能存在问题,需要一种或多种动态成像方式。本研究旨在比较CT和MRI对小肝癌诊断的敏感性和一致性。方法:由一名腹部放射科医生对根据2005年美国肝病研究学会(AASLD)标准经组织病理学或典型血管模式诊断的HCC(1-2 cm)的CT和/或MRI扫描进行盲法评估。当观察到动脉期强化和门静脉/延迟期廓清时,报告被定义为确定性/典型性,当未观察到典型血管模式时,报告被定义为非确定性。计算诊断的敏感性和一致性的Cohen's kappa(κ)值。结果:27例患者中,共纳入27个HCC结节(1-2 cm)。单一成像方式(CT或MRI)的诊断率分别为81%和48%(p = 0.01)。CT的敏感性显著高于MRI(78%对52%,p = 0.04)。在接受CT和MRI检查的27个结节中,发现典型强化模式存在不一致(κ = 0.319,p = 0.05)。在CT结果为非确定性的病例中,MRI仅额外提供3.7%的敏感性以达成诊断。相比之下,MRI结果为非确定性后进一步进行CT成像可额外提供29.6%的敏感性。结论:单一典型成像方式足以诊断小肝癌。与MRI相比,多期CT具有更高的敏感性。MRI的局限性可以通过对患者配合度的更高要求以及MRI造影剂的类型来解释。